Evidence map›Paper›PMID 37600513›Full record

ArticleFrontiers in aging neuroscience2023

Magnetic resonance imaging and neuropsychological findings for predicting of cognitive deterioration in memory clinic patients.

Kana Matsuda, Masaki Shinohara, Yuichiro Ii, Ken-Ichi Tabei, Yukito Ueda, Naoko Nakamura, Yoshinori Hirata, Hidehiro Ishikawa, Hirofumi Matsuyama, Keita Matsuura and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Neurovascular decoupling: An early indicator of cognitive decline.Journal of Alzheimer's disease : JAD · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Kana MatsudaDepartment of Dementia Prevention and Therapeutics, Mie University Graduate School of Medicine, Tsu, Japan.
Masaki ShinoharaDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Yuichiro IiDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Ken-Ichi TabeiDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Yukito UedaDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Naoko NakamuraDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Yoshinori HirataDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Hidehiro IshikawaDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Hirofumi MatsuyamaDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Keita MatsuuraDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Masayuki SatohDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Masayuki MaedaDepartment of Neuroradiology, Mie University Graduate School of Medicine, Tsu, Japan.
Ryo MomosakiDepartment of Rehabilitation Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
Hidekazu TomimotoDepartment of Neurology, Mie University Graduate School of Medicine, Tsu, Japan.
Akihiro ShindoDepartment of Dementia Prevention and Therapeutics, Mie University Graduate School of Medicine, Tsu, Japan.
Mie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The severity of cerebral small vessel disease (SVD) on magnetic resonance imaging (MRI) has been assessed using hypertensive arteriopathy SVD and cerebral amyloid angiopathy (CAA)-SVD scores. In addition, we reported the modified CAA-SVD score including cortical microinfarcts and posterior dominant white matter hyperintensity. Each SVD score has been associated with cognitive function, but the longitudinal changes remain unclear. Therefore, this study prospectively examined the prognostic value of each SVD score, imaging findings of cerebral SVD, and neuropsychological assessment. Methods: This study included 29 patients diagnosed with mild cognitive impairment or mild dementia at memory clinic in our hospital, who underwent clinical dementia rating (CDR) and brain MRI (3D-fluid attenuated inversion recovery, 3D-double inversion recovery, and susceptibility-weighted imaging) at baseline and 1 year later. Each SVD score and neuropsychological tests including the Mini-Mental State Examination, Japanese Raven's Colored Progressive Matrices, Trail Making Test -A/-B, and the Rivermead Behavioral Memory Test were evaluated at baseline and 1 year later. Results: Twenty patients had unchanged CDR (group A), while nine patients had worsened CDR (group B) after 1 year. At baseline, there was no significant difference in each SVD score; after 1 year, group B had significantly increased CAA-SVD and modified CAA-SVD scores. Group B also showed a significantly higher number of lobar microbleeds than group A at baseline. Furthermore, group B had significantly longer Japanese Raven's Colored Progressive Matrices and Trail Making test-A times at baseline. After 1 year, group B had significantly lower Mini-Mental State Examination, Japanese Raven's Colored Progressive Matrices, and Rivermead Behavioral Memory Test scores and significantly fewer word fluency (letters). Conclusion: Patients with worsened CDR 1 year after had a higher number of lobar microbleeds and prolonged psychomotor speed at baseline. These findings may become predictors of cognitive deterioration in patients who visit memory clinics.

Indexed as

cerebral amyloid angiopathy-small vessel disease scorehypertensive arteriopathy-small vessel disease scorememory clinicmild cognitive impairmentmild dementiamodified cerebral amyloid angiopathy-small vessel disease score

Identifiers

PMID37600513
PMCPMC10435295
OpenAlexW4385507256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.